Resumen

VILA BETANCOR, Julio Antonio; SOLIS PEREZ, Quenia  y  MEDINA BATISTA, Jorge. Therapeutic diagnostic update of Hughes antiphospholipid syndrome. ccm [online]. 2018, vol.22, n.3, pp.496-513. ISSN 1560-4381.

Antiphospholipid Syndrome is a disease of the immune system (thrombophilia), which is characterized by the association of antiphospholipid antibodies with recurrent thrombosis, abortions or recurrent fetal losses and thrombocytopenia. Initially described in systemic lupus erythematosus, it also appears in people who do not meet the criteria of a known disease, so its identification and treatment acquire great importance in people with apparently inexplicable thrombotic phenomena and in women with abortions and recurrent fetal deaths without other cause recognizable. Although the clinical phenomena that characterize this disease occur frequently, the incidence is low. So it is important, the identification of antiphospholipid antibodies through tests for their detection. Antiphospholipid Syndrome has no cure, but thrombotic events can be prevented by correcting the risk factors for thrombosis and using an oral anticoagulant therapy for the rest of your life.

Palabras clave : antiphospholipid syndrome; Hughes syndrome; thrombotic microangiopathy; antiphospholipid antibodies; anticardiolipins; lupus anticoagulants.

        · resumen en Español     · texto en Español     · Español ( pdf )